iifl-logo-icon 1

Bilcare Ltd Directors Report

57.99
(3.35%)
Oct 23, 2024|09:05:00 AM

Bilcare Ltd Share Price directors Report

The Members,

Your Directors are pleased to present the 37th Annual Report and the Audited Statements of Account for the year ended 31st March 2024.

Performance of the Company, State of Companys Affairs and Material Development

The Companys financial performance, for the year ended 31st March 2024 as per Ind AS is summarised below:

INR in Crs

Particulars

Standalone

Consolidated

2023-24 2022-23 2023-24 2022-23
Revenue from Operations including other income 26.18 17.71 769.70 991.84
Profit/ (Loss) before Interest, Depreciation, Tax and Exceptional Items (0.54) (3.41) 61.66 66.99
Exceptional Items 10.88 511.30 (6.63) 226.90
Profit/ (Loss) before Tax 5.70 502.92 (71.71) 196.08
Tax Expense (incl. Deferred Tax) 0.36 112.13 (13.17) 145.87
Profit/ (Loss) for the year (Owners of equity) 5.34 390.79 (33.24) 15.05
Non-controlling Interest -- -- (25.30) 35.16
Profit/ (Loss) for the year 5.34 390.79 (58.54) 50.21

Management Discussion and Analysis

As required by Regulation 34(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), a Management Discussion and Analysis Report is part of this Report.

The state of the affairs of the business along with the financial and operational developments has been discussed in detail in the Management Discussion and Analysis Report.

Directors & Key Managerial Personnel (KMP)

The following changes have been made to the Board of Directors & Key Managerial Personnel (KMP) of the Company during the year:

Mr. Ashwani Singh, Independent Director of the Company has resigned from the Board of Directors w.e.f. 4th October, 2023, before completion of his term as an Independent Director. He has resigned due to personal reasons and there being no material reasons other than those mentioned by him for his resignation as the Independent Director from the Board of Directors of the Company, the Board expressed and took on record its deep appreciation of the services rendered by Mr. Ashwani Singh during his tenure as a Director of the Company.

Mr. Vijesh Mehra, & Ms. Diksha Tomar, ceased to be Independent Directors of the Company w.e.f. 30th December, 2023 on account of completion of their term. The Board expressed and took on record its deep appreciation of the services rendered by Mr. Vijesh Mehra, & Ms. Diksha Tomar during their tenure as Independent Directors of the Company.

Ms. Prabhavi Mungee has resigned as the Company Secretary, Compliance Officer & Key Managerial Personnel of the Company with effect from 10th November, 2023.

Mr. Sagar R. Baheti is Appointed as the Company Secretary, Compliance Officer & Key Managerial Personnel of the Company with effect from 31st January, 2024.

Changes in Board Composition and Key Managerial Personnel post the Balance Sheet Date

The following changes have been made to the Board of Directors of the Company post the Balance Sheet date :

Mr. Pramod Toshniwal was appointed as an Independent Director of the Company w.e.f. 29th December 2023, has resigned from the Board of Directors w.e.f. 5th July 2024, before completion of his term as an Independent Director. He has resigned due to personal reasons and there being no material reasons other than those mentioned by him for his resignation as the independent Director from the Board of Directors of the Company, the Board expressed and took on record its deep appreciation of the services rendered by Mr. Pramod Toshniwal during his tenure as a Director of the Company.

Dr. Abhigyan Upadhyay (DIN 07267470) who was appointed as an Executive Director of the Company w.e.f. 29th December 2023, has vide his letter dated 9th July, 2024 has tendered his resignation as an Executive Director of the Company, due to personal reasons. He has also confirmed that there are no other material reasons for his resignation other than those mentioned in the resignation letter. However, he will continue to be on the Board of Directors of the Company as NonExecutive, Non-independent Director of the Company.

Ms. Alka Sagar is appointed as an Additional independent Director of the Company w.e.f. 14th August, 2024. Ms. Alka Sagar (BHSc. & LLB) is a private practitioner and court lawyer. She has more than 18 years of experience in the relevant field and serves as a board member in a Listed Company. She has the required integrity, expertise, experience and proficiency for appointment as a Non-Executive independent Director of the Company. Necessary resolutions seeking approval of members of the Company for regularization of appointment of Ms. Alka Sagar as Woman independent Director will be set out in the Notice convening the ensuing Annual General Meeting.

Declaration from Independent Directors

The Company has received declarations from all the Independent Directors of the Company confirming that they meet with the criteria of independence as prescribed both under sub section (6) of Section 149 of the Companies Act, 2013 and under SEBi Listing Regulations.

Annual Return

As per the requirements of Section 92(3) of the Act and Rules framed thereunder, Annual Return is available on the website of the company at www.bilcare-group.com.

Number of Meetings of the Board

During the Financial Year 2023-24, Nine (9) Board Meetings were held, details of which are given in the Corporate Governance Report section.

Directors Responsibility Statement

Pursuant to the requirement under the Section 134(5) of the Companies Act 2013, with respect to the Directors Responsibility Statement, it is hereby confirmed that:

a. in the preparation of the annual accounts for the financial year ended 31st March 2024, the applicable accounting standards had been followed and there are no material deviations from the same;

b, the directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at 31st March 2024 and of the Profit/loss of the Company for the year ended on that date;

c, the directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

d, the accounts for the financial year ended 31st March 2024 have been prepared on a going concern basis;

e, the directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively;

f, the directors had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively.

Particulars of Loans, Guarantees and Investments under section 186 of the Companies Act, 2013

Particulars of Loans, guarantees and investments form part of the notes to the financial statement provided in this Annual Report.

Contracts and Arrangements with Related Parties

During the year, the Company has not entered into any contract/ arrangement/ transaction with related parties which could be considered material in accordance with the policy of the Company on materiality of related party transactions and in accordance with the relevant provisions of Companies Act, 2013. All contracts/ arrangements/ transactions entered by the Company with related parties were in the ordinary course of business and on an arms length basis. Such transactions form part of the notes to the financial statements provided in this Annual Report. Accordingly, the disclosure of RPTs as required under the provisions of Section 134 of the Companies Act, 2013 read with Rule 8(2) of the Companies (Accounts) Rules, 2014 in Form AOC-2 is not applicable.

The Policy on materiality of related party transactions may be accessed on the Companys website at www.bilcare-group.com.

Amount Transfer to Reserves

Your Board of Directors do not propose to transfer any amount to the reserves.

Dividend

Your Board of Directors do not recommend any Dividend for the financial year ended 31st March 2024.

Conservation of Energy, Technology Absorption and Foreign exchange earnings & outgo

A. Conservation of Energy

i. Steps taken for Conservation of Energy:

Bilcare Focused on Energy conservation measures and successfully implemented as follows:

• Conversion of CFL higher watt light fitting to LED light fitting up to 900 Nos. of fittings saved Rs.5.13 Lacs per annum;

B. Technology Absorption, Adaptation and Innovation

During the financial year, 2 patents applied earlier were granted.

Further, 2 new patent applications were made for the PPI Division, which is transferred to Caprihans India Limited.

Expenditure on Research & Development -

i. During the financial year there is no R&D expenditure on a standalone basis.

ii. On a consolidated basis total R&D expenditure as a percentage of consolidated turnover is 0.20 %

Foreign Exchange Earnings & Outgo

Particulars Rs. in Crores
Foreign exchange earned 6.54
Foreign exchange outgo 0.31

Corporate Social Responsibility (CSR)

The Company has Corporate Social Responsibility Policy as per the Provisions of Companies Act, 2013 and Rules made thereunder and is available on the website of the Company.

The Annual Report on CSR acclivities is annexed as Annexure - A.

Audit Committee

The audit committee comprises of Mr. Rajesh Devene (Chairman of the Committee), Mrs.Madhuri Vaidya and Mr. Shreyans Bhandari as members. All the recommendations made by the committee were accepted by the Board.

Board Evaluation

Pursuant to the provisions of the Companies Act, 2013 and Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), the Board has carried out an annual performance evaluation of its own performance, the Directors individually as well as the evaluation of the working of its Committees. Performance evaluation has been carried out as per the Nomination and Remuneration Policy.

Independent Directors Meeting

In accordance with the provisions of Schedule IV (Code for Independent Directors) of the Companies Act, 2013 and SEBI Listing Regulations, a meeting of the Independent Directors of the Company was held on 13th February 2024 without the attendance of Non-Independent Directors and Members of the Management.

Information about Subsidiary/JV/ Associate Company

Consolidated Financial Statements of the Company are inclusive of the results of all the subsidiaries. Further, a statement containing the particulars for each of the subsidiaries is also enclosed. Copies of annual accounts and related information of all the subsidiaries can be sought by any member of the Company by making a written request to the Company at the Registered Office. Above information is available for inspection at the Registered Office & on website of the Company. A statement containing the salient features of the financial statement of the subsidiaries in the prescribed format is presented in a separate section forming part of the financial statement. The Policy for determining Material subsidiaries has been displayed on the Companys website at www.bilcare-group.com.

During the year, Bilcare Mauritius Limited (BML) has been liquidated and the investment of BML in its subsidiaries viz. Caprihans India Limited, Bilcare GCS Inc, Bilcare GCS Ireland Limited, Bilcare Inc and cash equivalent has been transferred to the shareholder viz. Bilcare Limited as part of the liquidation proceeds. There is no financial impact of the same in the financial results.

As on 31st March, 2024, Company has five (5) wholly owned subsidiaries viz. Bilcare GCS Limited, UK. Bilcare Inc., USA, Bilcare GCS Inc., USA, Bilcare GCS Ireland Limited and Bilcare Pharma Solutions Limited and Caprihans India Limited, a 51% subsidiary.

Deposits

Given below are the details of deposits, covered under Chapter V of the Companies Act, 2013:

The Company has not invited/accepted deposits from public/ members during the year under review.

The Company transferred its PPI Division to Caprihans India Limited, its Subsidiary as a business undertaking on a going concern basis on 27th March 2023 along with all the assets and liabilities pertaining to the PPI Division. Accordingly, Caprihans India Limited has undertaken to pay to the Company, the amount payable to the depositors. As on 31st March, 2024 the outstanding deposits were Rs. 79.69 Crs.

Significant and Material Orders

There are no significant and material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and Companys operations in future.

Internal Financial Controls

The Company has in place adequate internal financial controls with reference to financial statements. During the year, such controls were tested and no reportable material weaknesses in the design or operation were observed.

Vigil Mechanism

The Company has in place Whistle Blower Policy, wherein the Employees/ Directors/ Stakeholders of the Company are free to report any unethical or improper activity, actual or suspected fraud or violation of the Companys Code of Conduct. This mechanism provides safeguards against victimization of Employees, who report under the said mechanism. During the year under review, the Company has not received any complaints under the said mechanism. Your Directors hereby affirm that no personnel has been denied access to the audit committee. The Whistle Blower Policy may be accessed on the Companys website at www. bilcare-group.com.

Secretarial Standards Of ICSI

The Company is in compliance with relevant provisions of the Secretarial Standards issued by The Institute of Company Secretaries of India.

Corporate Governance

A report on Corporate Governance is given in this Annual Report. The requisite certificate from the Practicing Company Secretary confirming compliance with the conditions of corporate governance is attached to the report on Corporate Governance.

Auditors

Statutory Auditors

The Members of the Company in their meeting held on 29th September, 2023 appointed M/s. Sharp & Tannan Associates, Chartered Accountants (Firm Registration No. 109983W} as Statutory Auditors of the Company, for a period from the conclusion of Thirty Sixth Annual General Meeting till the conclusion of Forty First Annual General Meeting of the Company. The Auditors Report does not contain any qualification, reservation, adverse remark. The Notes on financial statement referred to in the Auditors Report are selfexplanatory and do not call for any further comment.

Secretarial Auditor

The Board had appointed M/s. Ghatpande & Ghatpande Associates Company Secretaries, to conduct Secretarial Audit for the financial year 2023-24. The Secretarial Audit Report for the financial year ended 31st March 2024 is annexed herewith marked as Annexure - B to this Report.

Managements explanation to the observations and comments given by the Auditors

As regards Auditors observations and comments on the Audit Trail feature, due to the shift of the operating system from SAP to S4-HANA, the same was not reflected w.e.f. 1st April, 2023. However, the said feature for Audit Trail is already enabled.

While filing the outcome of Board Meeting for the Quarter and FY ended 31st March, 2023, there was a delay in filing with BSE Ltd., by 1 hour and 6 minutes, due to technical issues with BSE Listing site. and the same was also clarified to BSE.

All the other observations and comments given by the Auditors are self-explanatory and do not call for any further comment.

Details in respect of fraud reported by auditors

During the year under review, the Statutory Auditor and Secretarial Auditor have not reported any instances of frauds committed in the Company by its Officers or Employees, to the Audit Committee under Section 143(12} of the Act details of which needs to be mentioned in this Report.

Particulars of Employees & Related Disclosures

Disclosures pertaining to remuneration and other details as required under Section 197(12} of the Act read with Rule 5(1} of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are provided as Annexure - C to this Report,

A statement containing particulars of employees as required under Section 197(12) of the Act read with Rules 5(2) and 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, is provided as a separate annexure forming part of this Report, However, the Annual Report is being sent to the members excluding the said annexure, The said information is available for electronic inspection during working hours and any member interested in obtaining such information may write to the Company Secretary or Registrar and Transfer Agent, and the same will be furnished on request,

General

Your Directors state that no disclosure or reporting is required in respect of the following items as there were no transactions on these items during the year under review:

1, Issue of equity shares with differential rights as to dividend, voting or otherwise,

2, Issue of shares (including sweat equity shares) to employees of the Company under any scheme save and except ESOS referred to in this Report, Mr, Shreyans Bhandari, Managing Director of the Company has received remuneration from Caprihans India Limited, subsidiary of the Company, in the capacity of President, During the year under review, no application is made and no proceeding is pending against the Company under the Insolvency and Bankruptcy Code, 2016 (IBC Code) and there is no instance of one-time settlement of the Company with any bank or financial institution.

During the year under review, there are no changes in the capital of the Company,

Disclosure under the Sexual Harassment of Women at workplace (Prevention, Prohibition and Redressal) Act 2013

in terms of provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013, the Company has formulated a Policy to prevent Sexual Harassment of Women at Workplace.

Your directors state that during the year under review, there were no complaints filed & there were no complaints pending at the end of the year pursuant to the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.

Acknowledgement

All other stakeholders We thank our domestic and international customers, vendors, investors, banking community and investment bankers for their continued support during the year.

Your directors also wish to place on record their deep sense of appreciation for the committed services of the employees at all levels worldwide.

We thank the Governments of various countries where we have our operations and also thank Central Government, various State Governments and other Government agencies for their positive co-operation and look forward to their continued support in future. Finally, we wish to express our gratitude to the members and shareholders for their trust and support.

For and on behalf of the Board of Directors

Shreyans Bhandari

Chairman & Managing

Director Pune : 14th August 2024

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp